Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Abbreviated, absent, accredited, agency, AIG, alleging, Amneal, ANDA, answer, Appendix, attached, BJIUVA, Book, chaired, combat, complaint, Composite, copy, counterclaim, Court, covenant, decile, District, Donegan, EBITDA, enjoining, entirety, equitable, ESPP, exceeded, exemption, exporting, faith, forward, Hong, incorporated, Incorporation, indemnify, induce, infringed, infringement, infringing, invalid, investor, issuable, Jersey, Karen, Kong, lesser, letter, lieu, Ling, live, maintenance, mcg, Michael, monitoring, moving, obsolescence, Orange, outreach, person, pharmacological, pick, pledged, prioritize, prioritizing, progressed, prohibited, promulgated, proxy, purport, put, quarantine, refocused, Restated, saving, Schedule, speaker, Teva, text, thereof, therewith, undrawn, unenforceable, USA, version, Vice, voluntarily
Removed:
broadly, call, deploying, discovery, exclude, fully, monthly, outsourced, PI
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 3.1 Composite Amended and Restated Articles of Incorporation
- 4.1 Form of Warrant to Purchase Common Stock
- 10.1 Amendment No. 2 to Financing Agreement
- 10.2 Amendment No. 3 to Financing Agreement
- 10.3 Amendment No. 4 to Financing Agreement
- 10.4 Amendment No. 5 to Financing Agreement,
- 10.5 Subscription Agreement,
- 10.6 Employment Agreement, by and Between Therapeuticsmd, Inc. and James C. D'arecca
- 31.1 Certification of Chief Executive Officer
- 31.2 Certification of Chief Financial Officer
- 32.1 Section 1350 Certification of Chief Executive Officer
- 32.2 Section 1350 Certification of Chief Financial Officer
- Download Excel data file
- View Excel data file
Related press release
Associated TXMD transcripts
TXMD similar filings
Filing view
External links
Exhibit 32.1
SECTION 1350 CERTIFICATION OF CHIEF EXECUTIVE OFFICER
In connection with the quarterly report of TherapeuticsMD, Inc. (the "Company") on Form 10-Q for the quarterly period ended June 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Robert G. Finizio, Chief Executive Officer of the Company, certify, to my best knowledge and belief, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
August 6, 2020 | /s/ Robert G. Finizio | |
Robert G. Finizio | ||
Chief Executive Officer | ||
(Principal Executive Officer) |
A signed original of this certification has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
48